Global Covid-19 Rapid Antigen Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Covid-19 Rapid Antigen Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Covid-19 Rapid Antigen by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Covid-19 Rapid Antigen by Country/Region, 2017, 2022 & 2028

2.2 Covid-19 Rapid Antigen Segment by Sample Type

2.2.1 Nasal Swab

2.2.2 Oral Fluid/Saliva

2.3 Covid-19 Rapid Antigen Sales by Sample Type

2.3.1 Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

2.3.2 Global Covid-19 Rapid Antigen Revenue and Market Share by Sample Type (2017-2022)

2.3.3 Global Covid-19 Rapid Antigen Sale Price by Sample Type (2017-2022)

2.4 Covid-19 Rapid Antigen Segment by Application

2.4.1 Hospitals

2.4.2 Scientific Research

2.5 Covid-19 Rapid Antigen Sales by Application

2.5.1 Global Covid-19 Rapid Antigen Sale Market Share by Application (2017-2022)

2.5.2 Global Covid-19 Rapid Antigen Revenue and Market Share by Application (2017-2022)

2.5.3 Global Covid-19 Rapid Antigen Sale Price by Application (2017-2022)

3 Global Covid-19 Rapid Antigen by Company

3.1 Global Covid-19 Rapid Antigen Breakdown Data by Company

3.1.1 Global Covid-19 Rapid Antigen Annual Sales by Company (2020-2022)

3.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Company (2020-2022)

3.2 Global Covid-19 Rapid Antigen Annual Revenue by Company (2020-2022)

3.2.1 Global Covid-19 Rapid Antigen Revenue by Company (2020-2022)

3.2.2 Global Covid-19 Rapid Antigen Revenue Market Share by Company (2020-2022)

3.3 Global Covid-19 Rapid Antigen Sale Price by Company

3.4 Key Manufacturers Covid-19 Rapid Antigen Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Covid-19 Rapid Antigen Product Location Distribution

3.4.2 Players Covid-19 Rapid Antigen Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Covid-19 Rapid Antigen by Geographic Region

4.1 World Historic Covid-19 Rapid Antigen Market Size by Geographic Region (2017-2022)

4.1.1 Global Covid-19 Rapid Antigen Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Covid-19 Rapid Antigen Annual Revenue by Geographic Region

4.2 World Historic Covid-19 Rapid Antigen Market Size by Country/Region (2017-2022)

4.2.1 Global Covid-19 Rapid Antigen Annual Sales by Country/Region (2017-2022)

4.2.2 Global Covid-19 Rapid Antigen Annual Revenue by Country/Region

4.3 Americas Covid-19 Rapid Antigen Sales Growth

4.4 APAC Covid-19 Rapid Antigen Sales Growth

4.5 Europe Covid-19 Rapid Antigen Sales Growth

4.6 Middle East & Africa Covid-19 Rapid Antigen Sales Growth

5 Americas

5.1 Americas Covid-19 Rapid Antigen Sales by Country

5.1.1 Americas Covid-19 Rapid Antigen Sales by Country (2017-2022)

5.1.2 Americas Covid-19 Rapid Antigen Revenue by Country (2017-2022)

5.2 Americas Covid-19 Rapid Antigen Sales by Sample Type

5.3 Americas Covid-19 Rapid Antigen Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Covid-19 Rapid Antigen Sales by Region

6.1.1 APAC Covid-19 Rapid Antigen Sales by Region (2017-2022)

6.1.2 APAC Covid-19 Rapid Antigen Revenue by Region (2017-2022)

6.2 APAC Covid-19 Rapid Antigen Sales by Sample Type

6.3 APAC Covid-19 Rapid Antigen Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Covid-19 Rapid Antigen by Country

7.1.1 Europe Covid-19 Rapid Antigen Sales by Country (2017-2022)

7.1.2 Europe Covid-19 Rapid Antigen Revenue by Country (2017-2022)

7.2 Europe Covid-19 Rapid Antigen Sales by Sample Type

7.3 Europe Covid-19 Rapid Antigen Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Covid-19 Rapid Antigen by Country

8.1.1 Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2017-2022)

8.1.2 Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2017-2022)

8.2 Middle East & Africa Covid-19 Rapid Antigen Sales by Sample Type

8.3 Middle East & Africa Covid-19 Rapid Antigen Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen

10.3 Manufacturing Process Analysis of Covid-19 Rapid Antigen

10.4 Industry Chain Structure of Covid-19 Rapid Antigen

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Covid-19 Rapid Antigen Distributors

11.3 Covid-19 Rapid Antigen Customer

12 World Forecast Review for Covid-19 Rapid Antigen by Geographic Region

12.1 Global Covid-19 Rapid Antigen Market Size Forecast by Region

12.1.1 Global Covid-19 Rapid Antigen Forecast by Region (2023-2028)

12.1.2 Global Covid-19 Rapid Antigen Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Covid-19 Rapid Antigen Forecast by Sample Type

12.7 Global Covid-19 Rapid Antigen Forecast by Application

13 Key Players Analysis

13.1 Abbott

13.1.1 Abbott Company Information

13.1.2 Abbott Covid-19 Rapid Antigen Product Offered

13.1.3 Abbott Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Main Business Overview

13.1.5 Abbott Latest Developments

13.2 Access Bio

13.2.1 Access Bio Company Information

13.2.2 Access Bio Covid-19 Rapid Antigen Product Offered

13.2.3 Access Bio Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Access Bio Main Business Overview

13.2.5 Access Bio Latest Developments

13.3 BD

13.3.1 BD Company Information

13.3.2 BD Covid-19 Rapid Antigen Product Offered

13.3.3 BD Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BD Main Business Overview

13.3.5 BD Latest Developments

13.4 Quidel

13.4.1 Quidel Company Information

13.4.2 Quidel Covid-19 Rapid Antigen Product Offered

13.4.3 Quidel Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Quidel Main Business Overview

13.4.5 Quidel Latest Developments

13.5 Fujirebio

13.5.1 Fujirebio Company Information

13.5.2 Fujirebio Covid-19 Rapid Antigen Product Offered

13.5.3 Fujirebio Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Fujirebio Main Business Overview

13.5.5 Fujirebio Latest Developments

13.6 Ellume

13.6.1 Ellume Company Information

13.6.2 Ellume Covid-19 Rapid Antigen Product Offered

13.6.3 Ellume Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ellume Main Business Overview

13.6.5 Ellume Latest Developments

13.7 OraSure Technologies

13.7.1 OraSure Technologies Company Information

13.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Offered

13.7.3 OraSure Technologies Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 OraSure Technologies Main Business Overview

13.7.5 OraSure Technologies Latest Developments

13.8 Clip Health

13.8.1 Clip Health Company Information

13.8.2 Clip Health Covid-19 Rapid Antigen Product Offered

13.8.3 Clip Health Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Clip Health Main Business Overview

13.8.5 Clip Health Latest Developments

13.9 Celltrion Healthcare

13.9.1 Celltrion Healthcare Company Information

13.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Offered

13.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Celltrion Healthcare Main Business Overview

13.9.5 Celltrion Healthcare Latest Developments

13.10 Salofa Oy

13.10.1 Salofa Oy Company Information

13.10.2 Salofa Oy Covid-19 Rapid Antigen Product Offered

13.10.3 Salofa Oy Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Salofa Oy Main Business Overview

13.10.5 Salofa Oy Latest Developments

13.11 iHealth Labs

13.11.1 iHealth Labs Company Information

13.11.2 iHealth Labs Covid-19 Rapid Antigen Product Offered

13.11.3 iHealth Labs Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 iHealth Labs Main Business Overview

13.11.5 iHealth Labs Latest Developments

13.12 Novegent

13.12.1 Novegent Company Information

13.12.2 Novegent Covid-19 Rapid Antigen Product Offered

13.12.3 Novegent Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novegent Main Business Overview

13.12.5 Novegent Latest Developments

13.13 Hangzhou Alltest Biotech

13.13.1 Hangzhou Alltest Biotech Company Information

13.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Offered

13.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Hangzhou Alltest Biotech Main Business Overview

13.13.5 Hangzhou Alltest Biotech Latest Developments

13.14 Guangzhou Decheng Biotechnology

13.14.1 Guangzhou Decheng Biotechnology Company Information

13.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Offered

13.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Guangzhou Decheng Biotechnology Main Business Overview

13.14.5 Guangzhou Decheng Biotechnology Latest Developments

13.15 SD Biosensor

13.15.1 SD Biosensor Company Information

13.15.2 SD Biosensor Covid-19 Rapid Antigen Product Offered

13.15.3 SD Biosensor Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 SD Biosensor Main Business Overview

13.15.5 SD Biosensor Latest Developments

13.16 MP Biomedical

13.16.1 MP Biomedical Company Information

13.16.2 MP Biomedical Covid-19 Rapid Antigen Product Offered

13.16.3 MP Biomedical Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 MP Biomedical Main Business Overview

13.16.5 MP Biomedical Latest Developments

13.17 Jiangsu Well Biotech

13.17.1 Jiangsu Well Biotech Company Information

13.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Offered

13.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Jiangsu Well Biotech Main Business Overview

13.17.5 Jiangsu Well Biotech Latest Developments

13.18 CTK Biotech

13.18.1 CTK Biotech Company Information

13.18.2 CTK Biotech Covid-19 Rapid Antigen Product Offered

13.18.3 CTK Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 CTK Biotech Main Business Overview

13.18.5 CTK Biotech Latest Developments

13.19 Hangzhou Laihe Biotech

13.19.1 Hangzhou Laihe Biotech Company Information

13.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Offered

13.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Hangzhou Laihe Biotech Main Business Overview

13.19.5 Hangzhou Laihe Biotech Latest Developments

13.20 Innovation Scientific

13.20.1 Innovation Scientific Company Information

13.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Offered

13.20.3 Innovation Scientific Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Innovation Scientific Main Business Overview

13.20.5 Innovation Scientific Latest Developments

13.21 Biohit Healthcare

13.21.1 Biohit Healthcare Company Information

13.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Offered

13.21.3 Biohit Healthcare Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Biohit Healthcare Main Business Overview

13.21.5 Biohit Healthcare Latest Developments

13.22 ACON Biotech

13.22.1 ACON Biotech Company Information

13.22.2 ACON Biotech Covid-19 Rapid Antigen Product Offered

13.22.3 ACON Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 ACON Biotech Main Business Overview

13.22.5 ACON Biotech Latest Developments

13.23 Assure Tech

13.23.1 Assure Tech Company Information

13.23.2 Assure Tech Covid-19 Rapid Antigen Product Offered

13.23.3 Assure Tech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Assure Tech Main Business Overview

13.23.5 Assure Tech Latest Developments

13.24 Hangzhou Clongene Biotech

13.24.1 Hangzhou Clongene Biotech Company Information

13.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Offered

13.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Hangzhou Clongene Biotech Main Business Overview

13.24.5 Hangzhou Clongene Biotech Latest Developments

13.25 Hangzhou Testsea Biotechnology

13.25.1 Hangzhou Testsea Biotechnology Company Information

13.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Offered

13.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Hangzhou Testsea Biotechnology Main Business Overview

13.25.5 Hangzhou Testsea Biotechnology Latest Developments

14 Research Findings and Conclusion

Table 1. Covid-19 Rapid Antigen Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Covid-19 Rapid Antigen Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Nasal Swab

Table 4. Major Players of Oral Fluid/Saliva

Table 5. Global Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)

Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

Table 7. Global Covid-19 Rapid Antigen Revenue by Sample Type (2017-2022) & ($ million)

Table 8. Global Covid-19 Rapid Antigen Revenue Market Share by Sample Type (2017-2022)

Table 9. Global Covid-19 Rapid Antigen Sale Price by Sample Type (2017-2022) & (US$/Unit)

Table 10. Global Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)

Table 11. Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Table 12. Global Covid-19 Rapid Antigen Revenue by Application (2017-2022)

Table 13. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2017-2022)

Table 14. Global Covid-19 Rapid Antigen Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Covid-19 Rapid Antigen Sales by Company (2020-2022) & (K Units)

Table 16. Global Covid-19 Rapid Antigen Sales Market Share by Company (2020-2022)

Table 17. Global Covid-19 Rapid Antigen Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Covid-19 Rapid Antigen Revenue Market Share by Company (2020-2022)

Table 19. Global Covid-19 Rapid Antigen Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Covid-19 Rapid Antigen Producing Area Distribution and Sales Area

Table 21. Players Covid-19 Rapid Antigen Products Offered

Table 22. Covid-19 Rapid Antigen Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Covid-19 Rapid Antigen Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Covid-19 Rapid Antigen Sales Market Share Geographic Region (2017-2022)

Table 27. Global Covid-19 Rapid Antigen Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Covid-19 Rapid Antigen Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Covid-19 Rapid Antigen Sales Market Share by Country/Region (2017-2022)

Table 31. Global Covid-19 Rapid Antigen Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Covid-19 Rapid Antigen Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)

Table 34. Americas Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)

Table 35. Americas Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)

Table 37. Americas Covid-19 Rapid Antigen Sales by Type (2017-2022) & (K Units)

Table 38. Americas Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

Table 39. Americas Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)

Table 40. Americas Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Table 41. APAC Covid-19 Rapid Antigen Sales by Region (2017-2022) & (K Units)

Table 42. APAC Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)

Table 43. APAC Covid-19 Rapid Antigen Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Covid-19 Rapid Antigen Revenue Market Share by Region (2017-2022)

Table 45. APAC Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)

Table 46. APAC Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

Table 47. APAC Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)

Table 48. APAC Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Table 49. Europe Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)

Table 50. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)

Table 51. Europe Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)

Table 53. Europe Covid-19 Rapid Antigen Sales by Type (2017-2022) & (K Units)

Table 54. Europe Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

Table 55. Europe Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)

Table 56. Europe Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)

Table 63. Middle East & Africa Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Covid-19 Rapid Antigen

Table 66. Key Market Challenges & Risks of Covid-19 Rapid Antigen

Table 67. Key Industry Trends of Covid-19 Rapid Antigen

Table 68. Covid-19 Rapid Antigen Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Covid-19 Rapid Antigen Distributors List

Table 71. Covid-19 Rapid Antigen Customer List

Table 72. Global Covid-19 Rapid Antigen Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Covid-19 Rapid Antigen Sales Market Forecast by Region

Table 74. Global Covid-19 Rapid Antigen Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Covid-19 Rapid Antigen Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Covid-19 Rapid Antigen Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Covid-19 Rapid Antigen Sales Forecast by Sample Type (2023-2028) & (K Units)

Table 85. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Sample Type (2023-2028)

Table 86. Global Covid-19 Rapid Antigen Revenue Forecast by Sample Type (2023-2028) & ($ Millions)

Table 87. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Sample Type (2023-2028)

Table 88. Global Covid-19 Rapid Antigen Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Covid-19 Rapid Antigen Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Application (2023-2028)

Table 92. Abbott Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 93. Abbott Covid-19 Rapid Antigen Product Offered

Table 94. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Abbott Main Business

Table 96. Abbott Latest Developments

Table 97. Access Bio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 98. Access Bio Covid-19 Rapid Antigen Product Offered

Table 99. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Access Bio Main Business

Table 101. Access Bio Latest Developments

Table 102. BD Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 103. BD Covid-19 Rapid Antigen Product Offered

Table 104. BD Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. BD Main Business

Table 106. BD Latest Developments

Table 107. Quidel Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 108. Quidel Covid-19 Rapid Antigen Product Offered

Table 109. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Quidel Main Business

Table 111. Quidel Latest Developments

Table 112. Fujirebio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 113. Fujirebio Covid-19 Rapid Antigen Product Offered

Table 114. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Fujirebio Main Business

Table 116. Fujirebio Latest Developments

Table 117. Ellume Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 118. Ellume Covid-19 Rapid Antigen Product Offered

Table 119. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Ellume Main Business

Table 121. Ellume Latest Developments

Table 122. OraSure Technologies Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 123. OraSure Technologies Covid-19 Rapid Antigen Product Offered

Table 124. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. OraSure Technologies Main Business

Table 126. OraSure Technologies Latest Developments

Table 127. Clip Health Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 128. Clip Health Covid-19 Rapid Antigen Product Offered

Table 129. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Clip Health Main Business

Table 131. Clip Health Latest Developments

Table 132. Celltrion Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 133. Celltrion Healthcare Covid-19 Rapid Antigen Product Offered

Table 134. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Celltrion Healthcare Main Business

Table 136. Celltrion Healthcare Latest Developments

Table 137. Salofa Oy Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 138. Salofa Oy Covid-19 Rapid Antigen Product Offered

Table 139. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Salofa Oy Main Business

Table 141. Salofa Oy Latest Developments

Table 142. iHealth Labs Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 143. iHealth Labs Covid-19 Rapid Antigen Product Offered

Table 144. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. iHealth Labs Main Business

Table 146. iHealth Labs Latest Developments

Table 147. Novegent Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 148. Novegent Covid-19 Rapid Antigen Product Offered

Table 149. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Novegent Main Business

Table 151. Novegent Latest Developments

Table 152. Hangzhou Alltest Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 153. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Offered

Table 154. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Hangzhou Alltest Biotech Main Business

Table 156. Hangzhou Alltest Biotech Latest Developments

Table 157. Guangzhou Decheng Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 158. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Offered

Table 159. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Guangzhou Decheng Biotechnology Main Business

Table 161. Guangzhou Decheng Biotechnology Latest Developments

Table 162. SD Biosensor Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 163. SD Biosensor Covid-19 Rapid Antigen Product Offered

Table 164. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. SD Biosensor Main Business

Table 166. SD Biosensor Latest Developments

Table 167. MP Biomedical Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 168. MP Biomedical Covid-19 Rapid Antigen Product Offered

Table 169. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. MP Biomedical Main Business

Table 171. MP Biomedical Latest Developments

Table 172. Jiangsu Well Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 173. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Offered

Table 174. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Jiangsu Well Biotech Main Business

Table 176. Jiangsu Well Biotech Latest Developments

Table 177. CTK Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 178. CTK Biotech Covid-19 Rapid Antigen Product Offered

Table 179. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. CTK Biotech Main Business

Table 181. CTK Biotech Latest Developments

Table 182. Hangzhou Laihe Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 183. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Offered

Table 184. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Hangzhou Laihe Biotech Main Business

Table 186. Hangzhou Laihe Biotech Latest Developments

Table 187. Innovation Scientific Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 188. Innovation Scientific Covid-19 Rapid Antigen Product Offered

Table 189. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Innovation Scientific Main Business

Table 191. Innovation Scientific Latest Developments

Table 192. Biohit Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 193. Biohit Healthcare Covid-19 Rapid Antigen Product Offered

Table 194. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 195. Biohit Healthcare Main Business

Table 196. Biohit Healthcare Latest Developments

Table 197. ACON Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 198. ACON Biotech Covid-19 Rapid Antigen Product Offered

Table 199. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 200. ACON Biotech Main Business

Table 201. ACON Biotech Latest Developments

Table 202. Assure Tech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 203. Assure Tech Covid-19 Rapid Antigen Product Offered

Table 204. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 205. Assure Tech Main Business

Table 206. Assure Tech Latest Developments

Table 207. Hangzhou Clongene Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 208. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Offered

Table 209. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 210. Hangzhou Clongene Biotech Main Business

Table 211. Hangzhou Clongene Biotech Latest Developments

Table 212. Hangzhou Testsea Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

Table 213. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Offered

Table 214. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 215. Hangzhou Testsea Biotechnology Main Business

Table 216. Hangzhou Testsea Biotechnology Latest Developments

List of Figures

Figure 1. Picture of Covid-19 Rapid Antigen

Figure 2. Covid-19 Rapid Antigen Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Covid-19 Rapid Antigen Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Covid-19 Rapid Antigen Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Covid-19 Rapid Antigen Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Nasal Swab

Figure 10. Product Picture of Oral Fluid/Saliva

Figure 11. Global Covid-19 Rapid Antigen Sales Market Share by Sample Type in 2021

Figure 12. Global Covid-19 Rapid Antigen Revenue Market Share by Sample Type (2017-2022)

Figure 13. Covid-19 Rapid Antigen Consumed in Hospitals

Figure 14. Global Covid-19 Rapid Antigen Market: Hospitals (2017-2022) & (K Units)

Figure 15. Covid-19 Rapid Antigen Consumed in Scientific Research

Figure 16. Global Covid-19 Rapid Antigen Market: Scientific Research (2017-2022) & (K Units)

Figure 17. Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)

Figure 18. Global Covid-19 Rapid Antigen Revenue Market Share by Application in 2021

Figure 19. Covid-19 Rapid Antigen Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Covid-19 Rapid Antigen Revenue Market Share by Company in 2021

Figure 21. Global Covid-19 Rapid Antigen Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region in 2021

Figure 23. Global Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)

Figure 24. Global Covid-19 Rapid Antigen Revenue Market Share by Country/Region in 2021

Figure 25. Americas Covid-19 Rapid Antigen Sales 2017-2022 (K Units)

Figure 26. Americas Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)

Figure 27. APAC Covid-19 Rapid Antigen Sales 2017-2022 (K Units)

Figure 28. APAC Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)

Figure 29. Europe Covid-19 Rapid Antigen Sales 2017-2022 (K Units)

Figure 30. Europe Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Covid-19 Rapid Antigen Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)

Figure 33. Americas Covid-19 Rapid Antigen Sales Market Share by Country in 2021

Figure 34. Americas Covid-19 Rapid Antigen Revenue Market Share by Country in 2021

Figure 35. United States Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Covid-19 Rapid Antigen Sales Market Share by Region in 2021

Figure 40. APAC Covid-19 Rapid Antigen Revenue Market Share by Regions in 2021

Figure 41. China Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2021

Figure 48. Europe Covid-19 Rapid Antigen Revenue Market Share by Country in 2021

Figure 49. Germany Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country in 2021

Figure 56. Egypt Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen in 2021

Figure 62. Manufacturing Process Analysis of Covid-19 Rapid Antigen

Figure 63. Industry Chain Structure of Covid-19 Rapid Antigen

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles